郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价A potent and selective S1P(1) antagonist with efficacy in experimental autoimmune encephalomyelitis.

期刊：Chemistry & biology发表年份：2012作者：Jean Quancard; Birgit Bollbuck; Philipp Janser; Daniela Angst; Frédéric Berst; Peter Buehlmayer; Markus Streiff; Christian Beerli; Volker Brinkmann; Danilo Guerini; Paul A Smith; Timothy J Seabrook; Martin Traebert; Klaus Seuwen; René Hersperger; Chr
阅读更多 →

药效评价Effect of cyclosporine and rifampin on the pharmacokinetics of macitentan, a tissue-targeting dual endothelin receptor antagonist.

期刊：The AAPS journal发表年份：2012作者：Shirin Bruderer; Päivi Aänismaa; Marie-Claude Homery; Stephanie Häusler; Kyle Landskroner; Patricia N Sidharta; Alexander Treiber; Jasper Dingemanse
阅读更多 →

药效评价Urocontrin, a novel UT receptor ligand with a unique pharmacological profile.

期刊：Biochemical pharmacology发表年份：2012作者：David Chatenet; Quang-Trinh Nguyen; Myriam Létourneau; Jocelyn Dupuis; Alain Fournier
阅读更多 →

药效评价Isolation, characterization and total regioselective synthesis of the novel μO-conotoxin MfVIA from Conus magnificus that targets voltage-gated sodium channels.

期刊：Biochemical pharmacology发表年份：2012作者：Irina Vetter; Zoltan Dekan; Oliver Knapp; David J Adams; Paul F Alewood; Richard J Lewis
阅读更多 →